Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review

Joachim Aidt Becker; Kasper Drimer Berg; Martin Andreas Røder; Klaus Brasso; Peter Iversen

doi:10.1080/21681805.2017.1363816

Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review

Joachim Aidt Becker, Kasper Drimer Berg, Martin Andreas Røder, Klaus Brasso, Peter Iversen

Institut for Klinisk Medicin

1 Citationer (Scopus)

Abstract

The impact of cytoreductive radical prostatectomy on oncological outcome in patients with prostate cancer and limited number of bone metastases is unclear. Data from cancer registries, multi-institutional databases and a single institutional case-control study indicate a possible benefit of combined cytoreduction and hormonal therapy compared to hormonal therapy alone. However, the results may be biased by a number of factors. The evidence from studies on cytoreductive prostatectomy is reviewed.

Originalsprog	Engelsk
Tidsskrift	Scandinavian Journal of Urology
Vol/bind	52
Udgave nummer	1
Sider (fra-til)	1-7
ISSN	0036-5599
DOI	https://doi.org/10.1080/21681805.2017.1363816
Status	Udgivet - 2 jan. 2018

FN’s Verdensmål

Dette resultat bidrager til følgende verdensmål

Adgang til dokumentet

10.1080/21681805.2017.1363816

Citationsformater

@article{b71febd897614f7cb5836fd7eff6f480,

title = "Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review",

abstract = "The impact of cytoreductive radical prostatectomy on oncological outcome in patients with prostate cancer and limited number of bone metastases is unclear. Data from cancer registries, multi-institutional databases and a single institutional case-control study indicate a possible benefit of combined cytoreduction and hormonal therapy compared to hormonal therapy alone. However, the results may be biased by a number of factors. The evidence from studies on cytoreductive prostatectomy is reviewed.",

author = "Becker, {Joachim Aidt} and Berg, {Kasper Drimer} and R{\o}der, {Martin Andreas} and Klaus Brasso and Peter Iversen",

year = "2018",

month = jan,

day = "2",

doi = "10.1080/21681805.2017.1363816",

language = "English",

volume = "52",

pages = "1--7",

journal = "Scandinavian Journal of Urology",

issn = "0036-5599",

publisher = "Taylor & Francis",

number = "1",

}

TY - JOUR

T1 - Cytoreductive prostatectomy in metastatic prostate cancer

T2 - a systematic review

AU - Becker, Joachim Aidt

AU - Berg, Kasper Drimer

AU - Røder, Martin Andreas

AU - Brasso, Klaus

AU - Iversen, Peter

PY - 2018/1/2

Y1 - 2018/1/2

N2 - The impact of cytoreductive radical prostatectomy on oncological outcome in patients with prostate cancer and limited number of bone metastases is unclear. Data from cancer registries, multi-institutional databases and a single institutional case-control study indicate a possible benefit of combined cytoreduction and hormonal therapy compared to hormonal therapy alone. However, the results may be biased by a number of factors. The evidence from studies on cytoreductive prostatectomy is reviewed.

AB - The impact of cytoreductive radical prostatectomy on oncological outcome in patients with prostate cancer and limited number of bone metastases is unclear. Data from cancer registries, multi-institutional databases and a single institutional case-control study indicate a possible benefit of combined cytoreduction and hormonal therapy compared to hormonal therapy alone. However, the results may be biased by a number of factors. The evidence from studies on cytoreductive prostatectomy is reviewed.

U2 - 10.1080/21681805.2017.1363816

DO - 10.1080/21681805.2017.1363816

M3 - Review

C2 - 28818014

SN - 0036-5599

VL - 52

SP - 1

EP - 7

JO - Scandinavian Journal of Urology

JF - Scandinavian Journal of Urology

IS - 1

ER -

Cytoreductive prostatectomy in metastatic prostate cancer: a systematic review

Abstract

FN’s Verdensmål

Adgang til dokumentet

Fingeraftryk

Citationsformater